Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Efficacy and safety of adalimumab (HUMIRA (R)) in...
Conference

Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The canact and the react trial to

Authors

Cividino A

Volume

64

Pagination

pp. 425-425

Publisher

BMJ PUBLISHING GROUP

Publication Date

July 1, 2005

Name of conference

Annual European Congress of Rheumatology

Conference place

Vienna, AUSTRIA

Conference start date

June 8, 2005

Conference end date

June 11, 2005

Conference proceedings

ANNALS OF THE RHEUMATIC DISEASES

ISSN

0003-4967

Labels